Q2 2025 · 13F-HR
AJU IB Investment Co., Ltd.holdings as filed
Filed 2025-07-10 · accession 0001140361-25-025427
$91.9M
Reported value
8
Positions
2025-06-30
Period end
The Brief · AJU IB Investment Co., Ltd. · Q2 2025
AI · grounded in 13F
AJU IB Investment Co., Ltd. established a new position in ACLXGBX valued at $68.98M. The fund also initiated a new stake in KYMR for $19.95M. Additional new positions include SEER at $1.75M, XILIO THERAPEUTICS INC at $453,998, and CARM at $281,299.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03940C100 | ACLXGBX | ARCELLX INC | $69.0M | 75.1% | 1,047,557 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $19.9M | 21.7% | 457,059 | Common | SOLE |
| 81578P106 | SEER | SEER INC | $1.7M | 1.90% | 816,375 | Common | SOLE |
| 98422T100 | XLO | XILIO THERAPEUTICS INC | $453,998 | 0.49% | 667,742 | Common | SOLE |
| 14216R101 | CARM | CARISMA THERAPEUTICS INC | $281,299 | 0.31% | 718,332 | Common | SOLE |
| 75120L100 | RLYB | RALLYBIO CORP | $255,081 | 0.28% | 754,678 | Common | SOLE |
| 869367102 | STRO | SUTRO BIOPHARMA INC | $124,933 | 0.14% | 175,000 | Common | SOLE |
| 75382E109 | RAPT | RAPT THERAPEUTICS INC | $99,496 | 0.11% | 12,437 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.